Correlation Between Anika Therapeutics and IShares ESG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and IShares ESG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and IShares ESG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anika Therapeutics and iShares ESG USD, you can compare the effects of market volatilities on Anika Therapeutics and IShares ESG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of IShares ESG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and IShares ESG.

Diversification Opportunities for Anika Therapeutics and IShares ESG

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Anika and IShares is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and iShares ESG USD in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares ESG USD and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with IShares ESG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares ESG USD has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and IShares ESG go up and down completely randomly.

Pair Corralation between Anika Therapeutics and IShares ESG

Given the investment horizon of 90 days Anika Therapeutics is expected to under-perform the IShares ESG. In addition to that, Anika Therapeutics is 12.92 times more volatile than iShares ESG USD. It trades about -0.12 of its total potential returns per unit of risk. iShares ESG USD is currently generating about -0.09 per unit of volatility. If you would invest  2,362  in iShares ESG USD on August 30, 2024 and sell it today you would lose (38.00) from holding iShares ESG USD or give up 1.61% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy97.73%
ValuesDaily Returns

Anika Therapeutics  vs.  iShares ESG USD

 Performance 
       Timeline  
Anika Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anika Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
iShares ESG USD 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares ESG USD has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, IShares ESG is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Anika Therapeutics and IShares ESG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anika Therapeutics and IShares ESG

The main advantage of trading using opposite Anika Therapeutics and IShares ESG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, IShares ESG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares ESG will offset losses from the drop in IShares ESG's long position.
The idea behind Anika Therapeutics and iShares ESG USD pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account